236 related articles for article (PubMed ID: 11728963)
1. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats.
Baylis C; Qiu C; Engels K
Am J Kidney Dis; 2001 Dec; 38(6):1292-7. PubMed ID: 11728963
[TBL] [Abstract][Full Text] [Related]
2. Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats.
Karam H; Clozel JP; Bruneval P; Gonzalez MF; Ménard J
Hypertension; 1999 Oct; 34(4 Pt 1):673-8. PubMed ID: 10523345
[TBL] [Abstract][Full Text] [Related]
3. L/N-type calcium channel blocker cilnidipine ameliorates proteinuria and inhibits the renal renin-angiotensin-aldosterone system in deoxycorticosterone acetate-salt hypertensive rats.
Toba H; Yoshida M; Tojo C; Nakano A; Oshima Y; Kojima Y; Noda K; Wang J; Kobara M; Nakata T
Hypertens Res; 2011 Apr; 34(4):521-9. PubMed ID: 21270815
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model.
Griffin KA; Picken M; Bakris GL; Bidani AK
Hypertension; 2001 May; 37(5):1268-72. PubMed ID: 11358939
[TBL] [Abstract][Full Text] [Related]
5. Ca2+ channel subtypes and pharmacology in the kidney.
Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
[TBL] [Abstract][Full Text] [Related]
6. Effects of calcium channel blockers on "dynamic" and "steady-state step" renal autoregulation.
Griffin KA; Hacioglu R; Abu-Amarah I; Loutzenhiser R; Williamson GA; Bidani AK
Am J Physiol Renal Physiol; 2004 Jun; 286(6):F1136-43. PubMed ID: 14996672
[TBL] [Abstract][Full Text] [Related]
7. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
Major TC; Dhamija S; Black N; Liachenko S; Morenko B; Sobocinski G; Okerberg C; Tinholt P; Madore S; Kowala MC
J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812
[TBL] [Abstract][Full Text] [Related]
8. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats.
Wagner C; Krämer BK; Hinder M; Kieninger M; Kurtz A
Br J Pharmacol; 1998 Jun; 124(3):579-85. PubMed ID: 9647484
[TBL] [Abstract][Full Text] [Related]
9. Effect of the novel T-selective calcium channel antagonist mibefradil on kidney function in comparison with amlodipine.
Greven J
Arzneimittelforschung; 1998 Aug; 48(8):806-10. PubMed ID: 9748707
[TBL] [Abstract][Full Text] [Related]
10. Azelnidipine attenuates glomerular damage in Dahl salt-sensitive rats by suppressing sympathetic nerve activity.
Nagasu H; Satoh M; Fujimoto S; Tomita N; Sasaki T; Kashihara N
Hypertens Res; 2012 Mar; 35(3):348-55. PubMed ID: 22072106
[TBL] [Abstract][Full Text] [Related]
11. Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes.
Ma G; Allen TJ; Cooper ME; Cao Z
Kidney Int; 2004 Sep; 66(3):1090-8. PubMed ID: 15327403
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
Min JY; Sandmann S; Meissner A; Unger T; Simon R
J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822
[TBL] [Abstract][Full Text] [Related]
13. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effects of the putative T-type calcium channel antagonist mibefradil are mediated by the L-type calcium channel Cav1.2.
Moosmang S; Haider N; Brüderl B; Welling A; Hofmann F
Circ Res; 2006 Jan; 98(1):105-10. PubMed ID: 16306443
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats.
Nakamura Y; Ono H; Frohlich ED
Hypertension; 1999 Aug; 34(2):273-8. PubMed ID: 10454453
[TBL] [Abstract][Full Text] [Related]
16. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
17. Divergent natriuretic action of calcium channel antagonists in mongrel dogs: renal haemodynamics as a determinant of natriuresis.
Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Ozawa Y; Saruta T
Clin Sci (Lond); 2001 Oct; 101(4):421-7. PubMed ID: 11566080
[TBL] [Abstract][Full Text] [Related]
18. Renal-protective effect of T-and L-type calcium channel blockers in hypertensive patients: an Amlodipine-to-Benidipine Changeover (ABC) study.
Ohishi M; Takagi T; Ito N; Terai M; Tatara Y; Hayashi N; Shiota A; Katsuya T; Rakugi H; Ogihara T
Hypertens Res; 2007 Sep; 30(9):797-806. PubMed ID: 18037772
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive agents and renal protection: calcium channel blockers.
Saruta T; Kanno Y; Hayashi K; Konishi K
Kidney Int Suppl; 1996 Jun; 55():S52-6. PubMed ID: 8743511
[TBL] [Abstract][Full Text] [Related]
20. Efonidipine reduces proteinuria and plasma aldosterone in patients with chronic glomerulonephritis.
Ishimitsu T; Kameda T; Akashiba A; Takahashi T; Ohta S; Yoshii M; Minami J; Ono H; Numabe A; Matsuoka H
Hypertens Res; 2007 Jul; 30(7):621-6. PubMed ID: 17785930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
